Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based SolutionAccesswire • Tuesday
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product LineAccesswire • 09/11/24
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common StockAccesswire • 08/28/24
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-DiffAccesswire • 08/26/24
Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United StatesAccesswire • 08/21/24
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced MomentumZacks Investment Research • 07/15/24
Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in UkraineAccesswire • 07/09/24
Sonoma Pharmaceuticals (SNOA) Shows Fast-paced Momentum But Is Still a Bargain StockZacks Investment Research • 06/28/24
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2024 Financial ResultsAccesswire • 06/17/24
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement StoresAccesswire • 05/09/24
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United StatesAccesswire • 04/09/24
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract InfectionsAccesswire • 04/04/24
Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor ConferencesAccesswire • 03/28/24
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other TopicalsAccesswire • 03/27/24
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-the-Counter Skincare Product for Daily UseAccesswire • 01/23/24
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma's Extensive Distributor NetworkBusiness Wire • 01/09/24
Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall ConferenceAccesswire • 11/03/23
Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common StockAccesswire • 10/26/23
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn AdvancedAccesswire • 08/15/23
Sonoma Pharmaceuticals Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory BoardAccesswire • 08/03/23